ADO has bottomed out, in my humble opinion. I also believe that certain entities overseas had a vested interested in making sure that their conversion period or the notes would fall within a period of low share price, for obvious reasons.
That is why I bought in continuously over several weeks, which I now have concluded.
OBJ is at the opposite spectrum of price appreciation compared to ADO.
The potential was factored into the OBJ price for some time now whereas ADO potential is virtually erased from the MC.
This, in my opinion, has to do with the transition from speculative to revenue based company.
New CEO, as I see it when I met him, through his already revenue producing company, over delivers and under promises, the opposite of the pump and dump game played on the ASX with so many companies.
It is the product expansion program within an already existing revenue creating company which makes the merger for me attractive.
- Forums
- ASX - By Stock
- WFL
- Ann: Shareholder Update June Quarter 2016-OBJ.AX
Ann: Shareholder Update June Quarter 2016-OBJ.AX, page-17
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online